| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 July 2026 |
| for |
| Pearce Urology Ltd |
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 July 2026 |
| for |
| Pearce Urology Ltd |
| Pearce Urology Ltd (Registered number: 07700771) |
| Contents of the Financial Statements |
| for the Year Ended 31 July 2026 |
| Page |
| Balance Sheet | 1 |
| Notes to the Financial Statements | 3 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Balance Sheet |
| 31 July 2026 |
| 31.7.26 | 31.7.25 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Investments | 6 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 7 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| PROVISIONS FOR LIABILITIES | 8 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 9 |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Pearce Urology Ltd (Registered number: 07700771) |
| Balance Sheet - continued |
| 31 July 2026 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements |
| for the Year Ended 31 July 2026 |
| 1. | STATUTORY INFORMATION |
| Pearce Urology Ltd is a |
| Registered number: |
| Registered office: |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2026 |
| 4. | TANGIBLE FIXED ASSETS |
| Fixtures |
| and | Motor |
| fittings | vehicles | Totals |
| £ | £ | £ |
| COST |
| At 1 August 2025 |
| Additions |
| Disposals | ( |
) | ( |
) |
| At 31 July 2026 |
| DEPRECIATION |
| At 1 August 2025 |
| Charge for year |
| Eliminated on disposal | ( |
) | ( |
) |
| At 31 July 2026 |
| NET BOOK VALUE |
| At 31 July 2026 |
| At 31 July 2025 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.7.26 | 31.7.25 |
| £ | £ |
| Other debtors |
| Prepayments |
| 6. | CURRENT ASSET INVESTMENTS |
| 31.7.26 | 31.7.25 |
| £ | £ |
| Listed investments | 106,602 | 93,245 |
| Unlisted investments | 7,675 | 7,675 |
| Market value of listed investments at 31 July 2026 - £ 106,602 (2025 - £ 93,245 ). |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.7.26 | 31.7.25 |
| £ | £ |
| Tax |
| Directors' current accounts | 4,252 | 2,331 |
| Accrued expenses |
| 8. | PROVISIONS FOR LIABILITIES |
| 31.7.26 | 31.7.25 |
| £ | £ |
| Deferred tax | 8,239 | 10,027 |
| Pearce Urology Ltd (Registered number: 07700771) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 July 2026 |
| 8. | PROVISIONS FOR LIABILITIES - continued |
| Deferred |
| tax |
| £ |
| Balance at 1 August 2025 |
| Utilised during year | ( |
) |
| Balance at 31 July 2026 |
| 9. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.7.26 | 31.7.25 |
| value: | £ | £ |
| Ordinary A | £1 | 60 | 60 |
| Ordinary B | £1 | 40 | 40 |
| Ordinary C | £1 | 1 | 1 |
| Ordinary D | £1 | 1 | 1 |
| 102 | 102 |
| 10. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
| The following advances and credits to directors subsisted during the years ended 31 July 2026 and 31 July 2025: |
| 31.7.26 | 31.7.25 |
| £ | £ |
| Balance outstanding at start of year | ( |
) | ( |
) |
| Amounts advanced |
| Amounts repaid | ( |
) | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year | ( |
) | ( |
) |
| 11. | ULTIMATE CONTROLLING PARTY |
| The controlling party is Dr I Pearce. |